Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: Ann Surg. 2023 May 19;278(2):161–165. doi: 10.1097/SLA.0000000000005903

TABLE 2.

Clinical Outcomes

RVHR (n = 54), n (%) LVHR (n = 47), n (%) P Relative risk (95% CI)
Follow-up duration, median (IQR) 2.30 (2.12, 2.62) 2.26 (2.03, 2.50) 0.463
Surgical site infection 0 0 1.000
Surgical site occurrence 7 (13) 4 (9) 0.460 1.55 (0.48–4.97)
   Seroma 7 (13) 4 (9) 0.460 1.55 (0.48–4.97)
   Hematoma 0 0 1.000
Hernia recurrence 2 (4) 6 (13) 0.124 0.30 (0.06–1.39)
Port site hernia 0 0 1.000
Readmission 0 3 (6) 0.097
Reoperation 0 5 (11) 0.019
Mortality 0 1 (2) 0.465

IQR indicates interquartile range; LVHR, laparoscopic ventral hernia repair; RVHR, robotic ventral hernia repair.